JUPITER, Fla., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic", "we", "us", "our", or the "Company") (NASDAQ: DYAI), a global biotechnology ...
Webcast Link:. https://viavid.webcasts.com/starthere.jsp?ei=1706029&tp_key=b177e95e36. An archive of the webcast will be available within 24 hours after completion of ...
Rapid commercial validation has been achieved through key partnerships disrupting high value/high growth markets Leadership team realigned in order to enable execution of ancillary protein strategy ...
Dyadic International, Inc. (NASDAQ:DYAI) and VTT have developed a production platform that boasts higher efficiency and lower cost based on Dyadic’s C1, Thermothelomyces heterothallica, expression ...
CompletedstrategicpivotfromR&Dfocustocommercial focus Rebranded as Dyadic Applied BioSolutions and launched redesigned website to optimize commercial engagement and ...
These events underscore Dyadic’s commitment to expanding its global footprint and advancing its mission to revolutionize biomanufacturing with its proprietary C1 and Dapibus™ technology platforms.
Reflects the Company’s strategic focus on commercializing non-therapeutic proteins and unlocking long-term value from its C1 and Dapibus™ gene expression platforms JUPITER, Fla.--(BUSINESS WIRE)-- ...
Dyadic International Inc. lost its $500 million lawsuit against Ernst & Young, but in the process it may have gotten help in pursuing Greenberg Traurig and other law firms it claims nearly destroyed ...
NEW YORK & TEL AVIV, Israel--(BUSINESS WIRE)--Dyadic Security, a leader in advanced cryptography solutions, today unveiled its Encryption and Key Protection Suite featuring two complementary new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results